Core Technology

ENERGI-F710  (Blood Phosphate Control)

Chronic nephrosis has afflicted over 500 million people worldwide and is one of top 10 death cases in Taiwan. The kidney of a nephrosis patient cannot dispel accumulation of blood phosphate, due to declining function, which poses as a risk factor for the deterioration of chronic nephrosis. Energenesis Biomedical's new medicine F710 is meant to help nephrosis patients control blood phosphate by lowering absorption of phosphate in food by the digestive tract, thereby lowering the risk of terminal nephrosis.